Startseite › Metastasierender Krebs › North Carolina › Durham
Klinische Studien zu Metastasierender Krebs in Durham, NC
33 Studien zu Metastasierender Krebs suchen Teilnehmer an Standorten in und um Durham (im Umkreis von ca. 30 Meilen). Öffnen Sie eine Studie, um Teilnahmevoraussetzungen und Kontaktdaten des Studienteams zu sehen.
Offizieller Studientext (Englisch)
BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)
Teilnehmer gesuchtPhase 1/2
- Avenzo Therapeutics Recruiting Site, Chapel Hill · 10 mi entfernt
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Teilnehmer gesuchtPhase 2
- Duke University Medical Center, Durham
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Teilnehmer gesuchtPhase 1/2
- Duke University, Durham
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
Teilnehmer gesuchtPhase 2/3
- Duke University Medical Center, Durham
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi entfernt
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Teilnehmer gesuchtPhase 3
- Duke Cancer Center - Investigational Chemotherapy Service, Durham
- Duke Cancer Center, Durham
- Duke University Hospital - Vascular Interventional Radiology, Durham
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
Teilnehmer gesuchtPhase 2
- Duke Cancer Institute, Durham
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Teilnehmer gesuchtPhase 2/3
- UNC Hospitals, The University of North Carolina at Chapel Hill, Chapel Hill · 10 mi entfernt
- University of North Carolina Hospitals at Hillsborough, Hillsborough · 13 mi entfernt
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Teilnehmer gesuchtPhase 3
- Duke Cancer Institute, Durham
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Teilnehmer gesuchtPhase 3
- University of North Carolina Medical Center, Chapel Hill · 10 mi entfernt
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Teilnehmer gesuchtPhase 3
- Duke Cancer Institute, Durham
- University of North Carolina Medical Center, Chapel Hill · 10 mi entfernt
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
Teilnehmer gesuchtPhase 1
- University of North Carolina (UNC) - Chapel Hill, Chapel Hill · 10 mi entfernt
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Teilnehmer gesuchtPhase 1/2
- Duke University, Durham
PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival
Teilnehmer gesucht
- Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill · 10 mi entfernt
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
Teilnehmer gesuchtPhase 1
- Duke Cancer Center, Durham
First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
Teilnehmer gesuchtPhase 1
- Research Site, Durham
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Teilnehmer gesuchtPhase 1
- Research Site, Durham
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Teilnehmer gesuchtPhase 1
- Duke Cancer Center, Durham
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
Teilnehmer gesuchtPhase 1/2
- Duke University Medical Center, Durham
UNC Childhood, Adolescent, and Young Adult Cancer Cohort
Teilnehmer gesuchtBeobachtungsstudie
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi entfernt
UNC Metastatic Cancer Radiation Therapy Registry
Teilnehmer gesuchtBeobachtungsstudie
- Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill, Chapel Hill · 10 mi entfernt
A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
Teilnehmer gesuchtPhase 1/2
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi entfernt
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
Teilnehmer gesuchtPhase 2/3
- Durham VA Medical Center, Durham, NC, Durham
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
Teilnehmer gesuchtPhase 2/3
- Duke University Medical Center, Durham
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
Teilnehmer gesuchtPhase 1/2
- Duke Cancer Center/ DUMC, Durham
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Teilnehmer gesuchtPhase 1
- Duke Cancer Institute, Durham
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen
Teilnehmer gesuchtPhase 3
- Duke University, Durham
Role of Ablative Radiotherapy in the Management of Metastatic Disease: A Patient Data Registry
Teilnehmer gesuchtBeobachtungsstudie
- Durham Veterans Administration Health Care System (DVAHCS), Durham
- Duke University Medical Center, Durham
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
Teilnehmer gesuchtPhase 1
- Duke Cancer Center, Durham
ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer
Teilnehmer gesuchtPhase 1
- Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi entfernt
JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors
Teilnehmer gesuchtPhase 1
- Duke University Medical Center - Duke Cancer Institute, Durham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Teilnehmer gesuchtBeobachtungsstudie
- Massive Bio SYNERGY-AI site, Chapel Hill · 10 mi entfernt
A Study to Provide Continued Access to and Assess Long-Term Safety of the Study Drug(s)
Teilnehmer gesuchtPhase 3
- Duke University - Trent Center, Durham
A Study of NX-1607 in Adults With Advanced Malignancies
Teilnehmer gesuchtPhase 1
- University of North Carolina, Chapel Hill · 10 mi entfernt
Metastasierender Krebs-Studien in anderen Städten
- Houston, TX104 Studien
- New York City, NY93 Studien
- Nashville, TN70 Studien
- Boston, MA63 Studien
- Los Angeles, CA57 Studien
- St. Louis, MO54 Studien
- Arlington, VA53 Studien
- Philadelphia, PA46 Studien
- Chicago, IL45 Studien
- San Antonio, TX44 Studien
- Washington, DC43 Studien
- Dallas, TX42 Studien
Weitere Studien in Durham
- Brustkrebs64 Studien
- Krebs (alle Arten)58 Studien
- Nichtkleinzelliges Lungenkarzinom39 Studien
- Multiples Myelom37 Studien
- Akute myeloische Leukämie33 Studien
- Prostatakrebs32 Studien
- Lungenkrebs32 Studien
- Kolorektales Karzinom28 Studien
- Eierstockkrebs27 Studien
- Chronische lymphatische Leukämie27 Studien
- Herzinsuffizienz26 Studien
- Bauchspeicheldrüsenkrebs24 Studien
Quelle: ClinicalTrials.gov, Daten abgerufen am 06.10.2026. Jede Studie legt ihre eigenen Teilnahmevoraussetzungen fest; das Studienteam entscheidet über die Zulassung.